logo

Genomic Health Inc. (GHDX)



Trade GHDX now with
  Date
  Headline
12/20/2017 7:28:22 AM William Blair Cuts Genomic Health Inc. (GHDX) To Market Perform From Outperform
12/6/2017 8:13:48 AM Genomic Health To Collaborate With Janssen Pharma To Evaluate Oncotype DX Genomic Prostate Score Test
9/13/2017 1:01:39 AM Genomic Health, Biocartis To Develop Idylla IVD Oncotype DX Breast Cancer Test To Broaden Global Patient Access
5/14/2017 12:21:14 AM Genomic Health Presents Prospective Oncotype DX Genomic Prostate Score Test Data
3/24/2017 8:04:44 AM Genomic Reports Publication Of Results From National Cancer Institute's Surveillance, Epidemiology, And End Results
12/13/2016 7:32:51 AM MetaStat Presents Positive Data From Two Clinical Studies Of MetaSite Breast
12/9/2016 8:42:54 AM Genomic Health Announces Results From Multiple Oncotype DX Studies
7/7/2016 12:30:44 AM Genomic Health And Epic Sciences Announce Strategic Collaboration To Deliver Novel AR-V7 Liquid Biopsy Test
11/16/2015 9:10:51 AM Canaccord Is Increasing Genomic Health Inc. (GHDX) 2016 Estimate To -0.06 From -0.10
11/16/2015 9:10:04 AM Canaccord Is Cutting Genomic Health Inc. (GHDX) 2015 Estimate To -0.94 From -0.85
11/16/2015 9:09:35 AM Canaccord Is Raising Genomic Health Inc. (GHDX) 2016 Rev. Estimate To 332.9 M From 328.0 M
11/16/2015 9:09:06 AM Canaccord Is Increasing Genomic Health Inc. (GHDX) 2015 Rev. Estimate To 291.4 M From 289.5 M
11/2/2011 12:16:39 PM RBC Capital Markets Is Cutting GENOMIC HEALTH, INC. (GHDX) 2012 Rev. Estimate To 231.1 M From 239.1 M
11/2/2011 12:16:21 PM RBC Capital Markets Is Cutting GENOMIC HEALTH, INC. (GHDX) 2011 Rev. Estimate To 205.8 M From 208.5 M
11/2/2011 12:16:02 PM RBC Capital Markets Is Cutting GENOMIC HEALTH, INC. (GHDX) Q4 11 Rev. Estimate To 53.1 M From 55.0 M
11/2/2011 12:15:17 PM RBC Capital Markets Is Increasing GENOMIC HEALTH, INC. (GHDX) 2012 Estimate To 0.33 From 0.22